- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, August 27, 2021
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by Wyoming News Now referenced an article published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The article, “A Timeline of COVID-19 Developments in 2020,” provides an overview of how the COVID-19 pandemic evolved and progressed last year.
A piece by VeryWellHealth featured an interview with Anthony Hagen, senior editor of AJMC®’s sister site The Center for Biosimilars®. In the piece, Hagen discussed how in the absence of biosimilar competition, originator companies are in some cases able to raise their drug prices to exorbitant levels.
Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC
July 31st 2025Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
Read More
Managed Care Reflections: A Q&A With Charles N. (Chip) Kahn III, MPH
July 30th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The August issue features a conversation with Charles N. (Chip) Kahn III, MPH, the president and CEO of the Federation of American Hospitals and a longtime member of the AJMC editorial board.
Read More
Contributor: Maternal Health Outcomes Are a Systemic Signal
July 15th 2025Jayme Ambrose, DNP, RN, CCM, of Adobe Population Health, explores how addressing social determinants of health transforms maternal care delivery, reduces disparities, and improves outcomes for mothers and infants.
Read More
